The extracellular matrix and the cytoskeleton in heart hypertrophy and failure

Heart Failure Reviews

Volumn 5, Issue 3, 2000, Pages 239-250

  Jane Lise, Samuel ^a,b   Corda, Stefano ^a,b   Chassagne, Catherine ^a,b   Rappaport, Lydie ^a,b  

^a IFR Circulation Paris 7 ^*  (United Kingdom)

^b Hop Fernand Vidal   (France)

Author keywords

Cardiac hypertrophy; Cytoskeleton; Failing heart; Fibrosis; Myocardium

Indexed keywords

ANGIOTENSIN; COLLAGEN; DESMIN; FIBRONECTIN; GROWTH FACTOR; INTEGRIN; LAMININ; MATRIX PROTEIN; METALLOPROTEINASE; TENASCIN;

CYTOSKELETON; EXTRACELLULAR MATRIX; FIBROSIS; HEART FAILURE; HEART HYPERTROPHY; HEART MUSCLE; HUMAN; MICROTUBULE; MUSCLE CELL; NONHUMAN; PATHOLOGY; PHYSIOLOGY; REVIEW; SARCOLEMMA; SIGNAL TRANSDUCTION;

ANIMALS; CARDIOMEGALY; CYTOSKELETAL PROTEINS; EXTRACELLULAR MATRIX; EXTRACELLULAR MATRIX PROTEINS; FIBRONECTINS; HEART FAILURE, CONGESTIVE; HUMANS; INTEGRINS; LAMININ; METALLOPROTEASES; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY; SIGNAL TRANSDUCTION;

EID: 0033711108     PISSN: 13824147     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1009857403356     Document Type: Review

References (111)

1. Various hypertrophic stimuli induce distinct phenotypes in cardiomycocytes
2. Different distributions of microtubules, desmin filaments and isomyosins during the onset of cardiac hypertrophy in the rat
3. Impairment of the myocardial ultrastructure and changes of the cytoskeleton in dilated cardiomyopathy
4. Human cardiac hypertrophy: Structural aspects
5. The role of the cytoskeleton in left ventricular pressure overload hypertrophy and failure
6. Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system
7. Fibronectin expression during physiological and pathological cardiac growth
8. Integrins: Versatility, modulation, and signaling in cell adhesion
9. Integrin signaling and cell growth control
10. Integrin transmembrane signaling and cytoskeletal control
11. Vascular endothelial growth factor stimulates tyrosine phosphorylation and recruitment to new focal adhesions of focal adhesion kinase and paxillin in endothelial cells
12. Integrins can collaborate with growth factors for phosphorylation of receptor tyrosine kinases and MAP kinase activation: Roles of integrin aggregation and occupancy of receptors
13. Angiotensin II stimulation of rapid paxillin tyrosine phosphorylation correlates with the formation of focal adhesions in rat aortic smooth muscle cells
14. Angiotensin II stimulates tyrosine phosphorylation of the focal adhesion-associated protein paxillin in aortic smooth muscle cells
15. Angiotensin II transduces its signal to focal adhesions via angiotensin II type 1 receptors in vascular smooth muscle cells
16. Cyclic strain induces reorganization of integrin alpha 5 beta 1 and alpha 2 beta 1 in human umbilical vein endothelial cells
17. Modulation of cardiac myocyte phenotype in vitro by the composition and orientation of the extracellular matrix
18. MLP-deficient mice exhibit a disruption of cardiac cytoarchitectural organization, dilated cardiomyopathy, and heart failure
19. Desmin is essential for the tensile strength and integrity of myofibrils but not for myogenic commitment, differentiation, and fusion of skeletal muscle
20. Stress pathways and heart failure
21. Microtubules in cardiac myocytes
22. Contractile and cytoskeletal content, structure, and mRNA levels with tachycardia-induced cardiomyopathy
23. Cardiac hypertrophic and developmental regulation of the beta-tubulin multigene family
24. Microtubule stabilization in pressure overload cardiac hypertrophy
25. Role of microtubules in the contractile dysfunction of hypertrophied myocardium
26. Cytoskeletal role in the transition from compensated to decompensated hypertrophy during adult canine left ventricular pressure overloading
27. Microtubules in cardiac hypertrophy: A mechanical role in decompensation?
28. Microtubule reorganization is related to rate of heart myocyte hypertrophy in rat
29. Microtubules and desmin filaments during onset of heart hypertrophy in rat: A double immunoelectron microscope study
30. Effects of chronic mitral regurgitation on diastolic function in isolated cardiocytes
31. Microtubules modulate cardiomyocyte beta-adrenergic response in cardiac hypertrophy
32. 2+ signaling in rat cardiac myocytes
33. Rabinovitch M. Nitric oxide mediates LC-3-dependent regulation of fibronectin in ductus arteriosus intimal cushion formation
34. Intermediate filaments in striated muscle. A review of structural studies in embryonic and adult skeletal and cardiac muscle
35. Desmin gene expression in cardiac myocytes is responsive to contractile activity and stretch
36. The association of cardiac dystrophin with myofibrils/Z-disc regions in cardiac muscle suggests a novel role in the contractile apparatus
37. The structural correlate of reduced cardiac function in human dilated cardiomyopathy
38. Disruption of muscle architecture and myocardial degeneration in mice lacking desmin
39. Null mutation in the desmin gene gives rise to a cardiomyopathy
40. The absence of desmin leads to cardiomyocyte hypertrophy and cardiac dilation with compromised systolic function
41. A missense mutation in the alphaB-crystallin chaperone gene causes a desmin-related myopathy
42. Association of mitochondria with plectin and desmin intermediate filaments in striated muscle
43. Targeted inactivation of plectin reveals essential function in maintaining the integrity of skin, muscle, and heart cytoarchitecture
44. Chronic pressure overload cardiac hypertrophy and failure in guinea pigs: II. Cytoskeletal remodeling
45. Expression of collagen adhesion proteins and their association with the cytoskeleton in cardiac myocytes
46. Dystrophin is not a specific component of the cardiac costamere
47. Dilated cardiomyopathy associated with deficiency of the cytoskeletal protein metavinculin
48. Vinculin knockout results in heart and brain defects during embryonic development
49. Extracellular signal-regulated kinase and c-Jun NH2-terminal kinase activation by mechanical stretch is integrin-dependent and matrix-specific in rat cardiac fibroblasts
50. Integrins, adhesion, and cardiac remodeling
51. Contact and adhesive specificities in the associations, migrations, and targeting of cells and axons
52. Expression of collagen binding integrins during cardiac development and hypertrophy
53. Beta 1D integrin displaces the beta 1A isoform in striated muscles: Localization at junctional structures and signaling potential in nonmuscle cells
54. Mechanical forces regulate focal adhesion and costamere assembly in cardiac myocytes
55. Differentiation and integrity of cardiac muscle cells are impaired in the absence of beta 1 integrin
56. Betal integrins participate in the hypertrophic response of rat ventricular myocytes
57. Differential onset of expression of alpha 7 and beta 1D integrins during mouse heart and skeletal muscle development
58. Muscle beta1D integrin reinforces the cytoskeleton-matrix link: Modulation of integrin adhesive function by alternative splicing
59. Knockout and knockin of the betal exon D define distinct roles for integrin splice variants in heart function and embryonic development
60. Association of tyrosine-phosphorylated c-Src with the cytoskeleton of hypertrophying myocardium
61. Cell adhesion molecules and matrix proteins; role in health and diseases
62. Complexity and specificity of integrin signalling
63. Binding of paxillin to alpha 4 integrins modifies integrin-dependent biological responses
64. Vascular endothelial growth factor induces activation and subcellular translocation of focal adhesion kinase (p125FAK) in cultured rat cardiac myocytes
65. Hypoxia induces activation and subcellular translocation of focal adhesion kinase (p125(FAK)) in cultured rat cardiac myocytes
66. The laminin family
67. Proteoglycans as modulators of growth factor activities
68. The extracellular matrix in human myocardium: Part I: Collagens I, III, IV, and VI
69. Regulation of cardiovascular collagen deposition by mechanical forces
70. Collagen network of the myocardium: Function structural remodeling and regulatory mechanisms
71. Cardiac hypertrophy-induced changes in mRNA levels for TGF-beta 1, fibronectin, and collagen
72. Biological determinants of aldosterone-induce cardiac fibrosis in rats
73. Regulation of fibrillar collagen types I and III and basement membrane type IV collagen gene expression in pressure overloaded rat myocardium
74. Remodeling of human myocardial collagen in idiopathic dilated cardiomyopathy. Role of metalloproteinases and pyridinoline cross-links
75. Collagen production and replication by cardiac fibroblasts is enhanced in response to diverse classes of growth factors
76. Remodeling of the rat right and left ventricles in experimental hypertension
77. Transition from hypertrophy to failure
78. Angiotensin AT1 receptor subtype as a cardiac target of aldosterone: Role in aldosterone-salt-induced fibrosis
79. Angiotensin II and myocyte growth: Role of fibroblasts
80. Renin-angiotensin system involvement in pressure-overload cardiac hypertrophy in rats
81. Pathophysiological role of angiotensin II type 2 receptor in cardiovascular and renal diseases
82. Angiotensin type 2 receptors are reexpressed by cardiac fibroblasts from failing myopathic hamster hearts and inhibit cell growth and fibrillar collagen metabolism
83. Activation of cardiac aldosterone production in rat myocardial infarction: Effect of angiotensin II receptor blockade and role in cardiac fibrosis
84. Extracellular matrix deposition in hypertensive hearts antifibrotic effects of ramipril
85. Effect of AT1 angiotensin-receptor blockade on structure and function of small arteries in SHR
86. Prostacyclin release by rat cardiac fibroblasts: Inhibition of collagen expression
87. Angiotensin II-induced myocardial fibrosis in rats: Role of nitric oxide, prostaglandins and bradykinin
88. Fibronectin: From gene to protein
89. Fibronectin expression in the normal and hypertrophic rat heart
90. Accumulation of fetal fibronectin mRNAs during the development of rat cardiac hypertrophy induced by pressure overload
91. Fibronectin and basement membrane in cardiovascular organogenesis and disease pathogenesis
92. Specific alterations in the distribution of extracellular matrix components within rat myocardium during the development of pressure overload
93. Angiotensin II induces fibronectin expression associated with cardiac fibrosis in the rat
94. Mechanism of angiotensin II-mediated regulation of fibronectin gene in rat vascular smooth muscle cells
95. Differential roles of AT1 and AT2 receptor subtypes in vascular trophic and phenotypic changes in response to stimulation with angiotensin II
96. Expression of laminin α2 chain during normal and pathological growth of myocardium in rat and human
97. Three muscular dystrophies: Loss of cytoskeleton-extracellular matrix linkage
98. Diverse effects of fibronectin and laminin on phenotypic properties of cultured arterial smooth muscle cells
99. In vitro studies on adult cardiac myocytes: Attachment and biosynthesis of collagen type IV and laminin
100. Regulation of extracellular matrix proteins in pressure-overload cardiac hypertrophy: Effects of angiotensin converting enzyme inhibition
101. Tenascins, a growing family of extracellular matrix proteins
102. The distribution of tenascin-X is distinct and often reciprocal to that of tenascin-C
103. Regulation of tenascin-C, a vascular smooth muscle cell survival factor that interacts with the alpha v beta 3 integrin to promote epidermal growth factor receptor phosphorylation and growth
104. Elastase and matrix metalloproteinase inhibitors induce regression, and tenascin-C antisense prevents progression, of vascular disease
105. Induction of tenascin-C in cardiac myocytes by mechanical deformation. Role of reactive oxygen species
106. Activation of matrix metalloproteinases in the failing human heart: Breaking the tie that binds
107. Matrix metalloproteinase degradation of extracellular matrix: Biological consequences
108. Changes in collagen phenotypes during progression and regression of cardiac hypertrophy
109. Differential regulation of matrix metalloproteinases associated with aging and hypertension in the rat heart
110. Differential expression of tissue inhibitors of metalloproteinases in the failing human heart
111. Extracellular matrix dynamics in heart failure: A prospect for gene therapy